Meet with... National Center for Advancing Translational Sciences

Add this event to your calendar:
17/09/2015 12:00 17/09/2015 15:00 America/Los_Angeles Meet with... National Center for Advancing Translational Sciences Biocom , 10996 Torreyana Rd , San Diego , CA 92121 JLABS San Diego false DD/MM/YYYY
September
17
Event

Meet with... National Center for Advancing Translational Sciences

Biocom , 10996 Torreyana Rd , San Diego , CA 92121

September 17, 2015 from 12:00 PM to 15:00 PM (PDT)

$10 - $35


JLABS SAN DIEGO EVENT Translation is a team sport and NCATS wants to play

Program Overview:
Meet with the newest institute at the NIH called the National Center for Advancing Translational Sciences (NCATS). By design, NCATS was formed to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster.

NCATS directly addresses the obstacles scientists face when developing a novel drug, device or other intervention. They are committed to uncovering new technologies and other approaches that could greatly accelerate the development and deployment of solutions that all translational researchers can use.

The NCATS approach is distinct in many ways and has already made a significant impact. Successes include 19 INDs that have been cleared by the FDA, twelve projects have been evaluated in clinical trials, and three agents have gone as far as Phase II human clinical trials. Additionally, third-party investors have licensed seven agents that have been developed through NCATS programs.

Join us to learn more about NCATS and their innovative approach. Following an overview of NCATS' opportunities and key areas of interest, don't miss the opportunity to introduce yourself during the networking lunch. Finally, for those companies who applied online and were approved, one-on-one meetings with NCATS will provide a forum to further discuss your company.

NCATS is seeking to collaborate with companies focusing on translating bench top discoveries to clinical hypothesis testing.

Agenda:
10:00 AM | Registration & Networking
10:30 AM | Presentation & Q&A
12:00 PM | Lunch & Networking
1:00 PM | One-on-one Meetings*
4:30 PM | Program Close

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on August 10th.

NCATS Participating Representatives:
Nora Yang | Director of Portfolio Management and Strategic Operations, National Center for Advancing Translational Sciences, National Institutes of Health read bio»
Anthony Jackson | Project Manager, BrIDGs Program, National Center for Advancing Translational Sciences, National Institutes of Health read bio»

About the National Center for Advancing Translational Sciences:
The National Center for Advancing Translational Sciences (NCATS) is the newest of 27 Institutes and Centers (ICs) at the National Institutes of Health (NIH). This Center was established in December 2011 to transform the translational science process so that new treatments and cures for disease can be delivered to patients faster. The mission of the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.
Read more about NCATS»
Connect with NCATS: Connect on LinkedIn Connect on Twitter

Fees:
Presentation & Lunch
$25 | General Public
$35 | General Public - At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until September 16th (or full).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. The one-on-one application period ends on August 10th. Your application will be reviewed and you will be notified of acceptance by email. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.

Venue:
Biocom
10996 Torreyana Rd
San Diego, CA

NCATS Representatives' Biographies:
Nora Yang Nora Yang | Director of Portfolio Management and Strategic Operations, National Center for Advancing Translational Sciences, National Institutes of Health
Nora Yang is the Director of Portfolio Management and Strategic Operations at the National Center for Advancing Translational Sciences (NCATS), NIH. In her current role, Nora Yang is responsible for planning, identifying and managing collaboration opportunities and partnerships, developing new business models to improve efficiency and effectiveness of translational sciences, building portfolio and project management capabilities, and implementing best practices of managing public and private partnerships for the NIH National Center for Advancing Translational Sciences (NCATS). She took a leadership role in building and managing the rare and neglected disease drug development portfolio within NCATS, which has taken 4 investigational drugs into rare disease patients in 7 clinical trials within 3 years. Within 4 years, 3 assets within the portfolio have been acquired by pharma partners with a collective deal value of US$1.12 billion. Prior to joining NCATS at NIH, Dr. Yang led global product development teams to manage and develop novel therapeutics for metabolic diseases and oncology indications at Eli Lilly & Co. and Amgen, Inc. She also worked with startup companies and VC firms to build and evaluate business plans and raise series A funding for startup companies. Nora holds a Ph.D. in chemistry from the Salk Institute of biological Research and the University of California, San Diego, and a Master's degree in business management from Stanford University, Graduate School of Business.
Connect with Nora: Connect on LinkedIn


Tony Jackson Anthony Jackson | Project Manager, BrIDGs Program, National Center for Advancing Translational Sciences, National Institutes of Health
Tony Jackson is a project manager in the NCATS Division of Preclinical Innovation, Therapeutics Development Branch. He is responsible for the Bridging Interventional Development Gaps program’s project onboarding process, collaborative agreements, budget management and outreach efforts. Tony also provides contract management expertise as a level II COR. Since he joined BrIDGs in 2006, the program has entered into more than 40 collaborations leading to 18 INDs. He worked in marketing at FDAnews, a pharmaceutical and medical device industry publishing company, and in the FDA’s Office of Biostatistics before joining NIH. Tony earned a B.S. in Business Administration from Carnegie Mellon University with a focus on communications.
Connect with Tony: Connect on LinkedIn



About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Thomas McNerney & Partners, NCATS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.


JLABS San Diego

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit www.jlabs.jnjinnovation.com or follow @JLABS.

Event contact


Related content